Westrock Coffee Company (NASDAQ: WEST) is a vertically integrated beverage company handling the full coffee supply chain — from green-bean sourcing in Rwanda and Ethiopia through roasting, extract/RTD manufacturing, and branded/private-label packaging (bags, fractional packs, single-serve cups). Westrock came public via SPAC (Riverview Acquisition Corp.) in October 2021 and is headquartered in Little Rock, AR, with CEO and co-founder Scott T. Ford as its largest individual executive stakeholder.
The company operates in two reportable segments: (1) Beverage Solutions — the core value-add business (roasting, extract, RTD, packaging, contract manufacturing for retail, foodservice, convenience, CPG, and hospitality customers); and (2) Sustainable Sourcing & Traceability (SS&T) — a green-coffee trading and forward-contract management operation that is largely pass-through revenue with minimal margin. The SS&T segment inflates top-line revenue but contributes little to profitability; investors should focus on Beverage Solutions unit economics.
FY2025 revenue surged +39.8% to $1.19B driven primarily by SS&T volume and new Beverage Solutions customer onboarding from the Conway facility. The company is unprofitable at the net income level (FY2025 net loss: –$90.4M, EPS: –$0.94), carries $532M net debt, and has burned over $630M of FCF cumulatively since 2021 — entirely attributable to building and equipping the Conway, AR manufacturing campus.
Investment Thesis — Conway Ramp or Cash-Burn Trap?
The Conway, Arkansas facility is the central bet. Westrock invested ~$400M+ in a greenfield manufacturing campus featuring single-serve cup lines, extract/RTD production, and co-packing capabilities. The thesis: once Conway reaches scale, operating leverage kicks in — SG&A deleverages, gross margins recover from the current ~10% trough (depressed by pre-ramp startup costs), and the company inflects toward positive EBITDA and eventually free cash flow.
Q1 2026 results provided the first tangible evidence of inflection: management reported "sharply higher" first-quarter results and reaffirmed 2026 guidance, describing the company as having "moved beyond a multiyear investment phase." Capex is declining ($89M in FY2025 vs. $160M in FY2024), net losses are narrowing, and the 2025 revenue surge demonstrates that customer volumes are materializing.
The counterargument is real: gross margin collapsed from 18% (FY2024) to 10% (FY2025) as elevated arabica/robusta coffee costs, SS&T mix shift, and pre-ramp absorption hit simultaneously. With $532M net debt, $102M current short-term debt maturities, and ongoing operating losses, the company's liquidity trajectory demands close monitoring. Failure to ramp Conway on schedule — or a sustained spike in green-coffee prices — would force dilutive equity issuance or covenant risk.
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $698.1M | $867.9M | $864.7M | $850.7M | $1,189.0M |
| Revenue Growth | — | +24.3% | –0.4% | –1.6% | +39.8% |
| Gross Profit | $145.4M | $152.8M | $139.9M | $153.8M | $122.6M |
| Gross Margin | 20.8% | 17.6% | 16.2% | 18.1% | 10.3% |
| SG&A | $128.5M | $130.0M | $144.6M | $185.1M | $185.5M |
| Operating Income | $7.8M | $8.7M | –$20.4M | –$49.1M | –$62.8M |
| Operating Margin | 1.1% | 1.0% | –2.4% | –5.8% | –5.3% |
| EBITDA | $33.4M | $4.4M | $14.9M | –$7.8M | $19.4M |
| EBITDA Margin | 4.8% | 0.5% | 1.7% | –0.9% | 1.6% |
| Interest Expense | –$32.5M | –$35.5M | –$29.2M | –$33.9M | –$55.7M |
| Net Income | –$21.9M | –$55.2M | –$34.6M | –$80.3M | –$90.4M |
| EPS (Diluted) | –$1.34 | –$1.60 | –$0.43 | –$0.89 | –$0.94 |
| Wtd Avg Shares | 34.5M | 48.4M | 80.7M | 89.8M | 95.4M |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $19.3M | $16.8M | $37.2M | $26.2M | $49.9M |
| Total Current Assets | $238.0M | $298.1M | $313.1M | $333.6M | $396.4M |
| PP&E (Net) | $127.6M | $196.3M | $411.6M | $530.4M | $543.9M |
| Goodwill & Intangibles | $223.0M | $244.9M | $239.1M | $231.0M | $223.3M |
| Total Assets | $593.0M | $746.2M | $971.5M | $1,101.8M | $1,176.0M |
| Short-Term Debt | $47.4M | $54.4M | $53.5M | $68.7M | $101.9M |
| Total Current Liabilities | $168.2M | $216.1M | $239.6M | $277.9M | $413.6M |
| Long-Term Debt | $290.4M | $162.5M | $223.1M | $375.6M | $421.5M |
| Total Debt | $337.8M | $225.3M | $340.2M | $505.0M | $581.6M |
| Net Debt | $318.5M | $208.5M | $303.0M | $478.8M | $531.7M |
| Preferred Stock | $281.9M | $274.9M | $274.2M | $273.9M | $273.5M |
| Total Equity | $105.9M | $286.7M | $388.0M | $371.3M | $271.6M |
| Retained Earnings (Deficit) | –$251.7M | –$328.0M | –$362.6M | –$442.9M | –$534.4M |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $2.9M | –$56.6M | –$64.1M | –$13.2M | –$19.0M |
| Capital Expenditures | –$25.4M | –$63.4M | –$164.8M | –$159.6M | –$88.8M |
| Free Cash Flow | –$22.6M | –$120.1M | –$228.8M | –$172.9M | –$107.8M |
| D&A | $25.5M | $24.2M | $26.6M | $34.7M | $55.8M |
| Stock-Based Compensation | $1.2M | $2.6M | $8.7M | $11.6M | $14.6M |
| Net Debt Issuance | $8.4M | –$104.3M | $59.3M | $168.9M | $84.2M |
| Common Stock Issuance | — | $230.9M | $118.8M | $0.6M | $11.9M |
| Net Financing Cash Flow | $23.8M | $134.7M | $244.2M | $156.6M | $136.7M |
| Dividends Paid | — | — | — | — | — |
| Multiple | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 (Current) |
|---|---|---|---|---|---|
| Revenue | $698M | $868M | $865M | $851M | $1,189M |
| Market Cap (at $9.19) | — | — | — | — | $876M |
| Enterprise Value | — | — | — | — | $1,408M |
| EV / Sales | 0.94x | 0.99x | 1.30x | 1.24x | 1.18x |
| Price / Sales | 0.48x | 0.75x | 0.95x | 0.68x | 0.74x |
| EV / EBITDA | 19.6x | 196x | 75.5x | N/M | 72.6x |
| P/E (TTM) | N/M | N/M | N/M | N/M | N/M |
| Price / Book | 3.26x | 2.28x | 2.12x | 1.55x | 3.23x |
| Debt / EBITDA | 10.1x | 51.8x | 22.8x | N/M | 30.0x |
| Net Debt / EBITDA | 9.5x | 47.9x | 20.3x | N/M | 27.4x |
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | –21.3% | –19.4% | –8.9% | –21.6% | –33.3% |
| Return on Assets (ROA) | –3.7% | –7.4% | –3.6% | –7.3% | –7.7% |
| Return on Invested Capital | 1.4% | 1.5% | –2.2% | –5.5% | –7.1% |
| Asset Turnover | 1.18x | 1.16x | 0.89x | 0.77x | 1.01x |
| Inventory Turnover | 5.1x | 4.9x | 4.8x | 4.3x | 5.3x |
| Current Ratio | 1.41x | 1.38x | 1.31x | 1.20x | 0.96x |
| Quick Ratio | 0.77x | 0.70x | 0.68x | 0.61x | 0.48x |
| Interest Coverage (EBIT/Int) | 0.24x | 0.24x | –0.70x | –1.45x | –1.13x |
| Capex / Revenue | 3.6% | 7.3% | 19.1% | 18.8% | 7.5% |
| SG&A / Revenue | 18.4% | 15.0% | 16.7% | 21.8% | 15.6% |
| Metric | FY2025A | FY2026E | FY2027E |
|---|---|---|---|
| Revenue (Avg) | $1,189M | $1,310M | $1,457M |
| Revenue (Range) | Actual | $1,290–$1,330M | $1,426–$1,488M |
| EBITDA (Avg) | $19.4M | $20.2M | $22.5M |
| Net Income (Avg) | –$90.4M | –$17.3M | –$2.9M |
| EPS (Avg) | –$0.94A | –$0.18 | –$0.03 |
| Fwd P/E | N/M | N/M | N/M (near B/E) |
| Fwd EV/Sales | 1.18x | 1.08x | 0.97x |
| # Analysts (Rev) | 3–4 | 3 | 3 |
| # Analysts (EPS) | 2 | 1 | 1 |
Coverage is thin (3 analysts). The current price has rallied above recent PT levels — the stock is pricing in Conway ramp execution ahead of street models. If Q2 or Q3 2026 data disappoint, there is no analytical floor from consensus.
| Filing Date | Name / Role | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Ford, Scott T. — CEO | Gift (Indirect) | 55,000 | — | — |
| 2026-06-09 | Harvey, Larry K. — SVP & CLO | Award | 20,359 | — | — |
| 2026-06-08 | Parent, Kenneth M. — Director | Award | 41,992 | — | — |
| 2026-06-08 | Multiple Directors (7) | Awards | ~75,586 | — | — |
| 2026-06-02 | Ford, Joe T. — Director (Founder) | Open Mkt Buy | 3,000 | $8.04 | $24,120 |
| 2026-05-15 | Ford, Joe T. — Director (Founder) | Open Mkt Buy | 26,500 | $8.43–8.50 | ~$224K |
Constructive signal: Founder/director Joe T. Ford has made multiple open-market purchases in May–June 2026 at $8.04–$8.50, totaling ~$248K. CEO Scott T. Ford (Joe's son) retains a large stake (55K shares disposed via gift). No open-market sales visible among insiders in recent filings. Ford family buying at current levels is one of the stronger qualitative signals for this story.
Bull Case — Conway Ramp Inflection
Operating leverage materializes: Conway, AR hits utilization thresholds in 2026–2027, driving SG&A deleverage and gross margin recovery from the 10% trough back toward 16–20%. With capex stepping down (from $160M in FY2024 to $89M in FY2025 and likely below $60M by FY2027), FCF turns toward positive for the first time.
Large contracted volume backlog: Westrock built Conway to serve specific long-term contractual customers in single-serve cups and RTD extract. Once production lines achieve full throughput, those contracted volumes translate directly to fixed-cost absorption and margin expansion — a high-visibility revenue ramp rather than speculative market capture.
RTD/extract secular tailwind: Ready-to-drink coffee, iced coffee, and cold-brew formats are among the fastest-growing beverage categories. Westrock's extract and RTD manufacturing capability is scarce and capital-intensive to replicate — creating defensible positioning for the Beverage Solutions segment.
Debt-service improvement: As EBITDA grows toward the $70–100M guidance range cited by sell-side, net debt / EBITDA compresses rapidly from 27x toward 5–7x, reducing refinancing and dilution risk.
Bear Case — Cash Burn & Dilution Spiral
Gross margin collapse persists: FY2025 gross margin fell to a five-year low of 10.3%, and the culprits — elevated arabica and robusta prices, SS&T pass-through mix shift, and pre-ramp absorption — may not resolve quickly. Arabica coffee futures remain structurally elevated (multi-year high cycle). If green-coffee costs stay high and customer contracts don't include effective price-escalators, the ramp produces revenue without margin.
Liquidity crunch: With $102M in short-term debt maturities, a current ratio below 1.0x, and ongoing operating losses, the company needs continued debt market access. A tightening credit environment, covenant trigger, or lender hesitation could force an equity raise at dilutive prices. Cumulative net losses of $534M already show the cost of this buildout.
Execution risk is high: Single-facility concentration at Conway creates operational risk — any equipment failure, ramp delay, or customer volume shortfall has outsized impact. Management credibility was tested during the multi-year buildout; any slip in the FY2026 ramp timeline would likely reprice the stock sharply lower.
Thin analyst coverage = no floor: With only 3 covering analysts and price targets already below the current price, a negative data point has no institutional support underneath. SPAC vintage + thin coverage + high leverage = volatile downside.
Arabica and robusta green-coffee prices are at multi-year highs. Westrock is exposed through both its Beverage Solutions cost of goods and SS&T trading positions. Limited pricing power in private-label contracts compresses pass-through ability. Green-coffee can represent 40–60% of COGS in the Beverage Solutions segment.
$581.6M total debt, current ratio 0.96x (below 1.0), net debt / EBITDA 27.4x, and negative operating cash flow. Interest expense of $55.7M in FY2025 (vs. EBITDA of $19.4M) means the company cannot service debt from earnings. Refinancing risk is real if lenders tighten or rates rise.
The entire thesis depends on Conway reaching utilization targets on schedule. Any delay in customer onboarding, line commissioning, or equipment qualification extends the cash-burn window and increases dilution risk. Conway is a single-facility, single-failure-point operation for the company's growth plan.
Share count has tripled since 2021 (34.5M → 95.4M). The company continues to fund operations partly through equity issuance. If FCF does not turn positive in 2026–2027 as modeled, further dilutive equity raises are likely. Preferred stock ($273.5M) represents an additional claim senior to common.
Westrock serves retail, foodservice, convenience, and CPG customers under long-term contracts but the identity and volume commitments of top customers are not fully disclosed. Loss of a major Beverage Solutions customer during the ramp phase would be highly disruptive given the fixed-cost structure at Conway.
SPAC structure brings elevated SPAC-vintage warrants, founder-share dilution mechanics, and historically lower institutional quality standards. The Ford family's dual-CEO/director presence and related-party relationships (Joe T. Ford, Scott T. Ford) warrant normal governance scrutiny for founder-controlled companies.
Management reported "sharply higher" Q1 2026 results and declared the company has "moved beyond a multiyear investment phase," now operating as an integrated beverage platform. First meaningful sign that the Conway thesis is materializing.
Q1 EPS loss of –$0.04 vs. –$0.22 a year ago — a significant year-over-year improvement. Revenue beat consensus. Company reiterated FY2026 guidance, supporting sell-side confidence in the ramp trajectory.
Despite shares up 16.7% since February, analyst maintains Hold. Notes EBITDA projected to rise from ~$70M in 2025 to $90–100M in 2026 (significantly above FMP's FY2025 EBITDA of $19.4M — likely guidance-based). Valuation "reasonable but not cheap" at current levels.
Multiple director award grants (June 5, 2026). Founder and director Joe T. Ford purchased 3,000 shares at $8.04 on June 1, following 26,500 shares purchased at $8.43–$8.50 in mid-May. Constructive signal of insider conviction near current prices.
Standard earnings date announcement. Q2 2026 results expected approximately August 2026 — the next major catalyst for confirming or refuting the Conway ramp trajectory across two consecutive quarters.
Annual report confirmed Conway facility complete and operational. FY2025 revenue $1.19B (+39.8%), net loss –$90.4M. Gross margin compression to 10.3% attributed to SS&T mix and coffee cost headwinds. Capex declining sharply — structural evidence the buildout phase is ending.
Assumptions: Conway hits 80%+ utilization by mid-2026; FY2026E revenue of $1.31B achieved; EBITDA inflects to $70–80M range (Seeking Alpha/management guidance band); capex drops to <$50M. FCF approaches breakeven.
Valuation: At 1.3–1.5x EV/Sales on $1.31B revenue (EV $1.70–1.97B), less net debt of ~$470M → equity value $1.23–$1.50B. Shares ~97M → $12.70–$15.50. Add any EBITDA re-rating to 20–25x forward ($70M EBITDA × 22x = $1.54B EV) → $11–$14. Blended target: $14–$17. Coffee cost normalization amplifies upside.
Assumptions: Conway ramp progresses but slower than bull case; FY2026E revenue $1.25–$1.31B; EBITDA $20–35M (modest improvement from FY2025's $19.4M); capex $70–90M; FCF still negative but improving. Gross margin recovery to 12–14%.
Valuation: At 1.0–1.2x EV/Sales on ~$1.28B revenue (EV $1.28–$1.54B), less net debt of ~$510M → equity value $770M–$1.03B. Shares ~97M → $7.90–$10.60. EV/EBITDA on $25M EBITDA at 35x = EV $875M → equity ~$345M ($3.55/sh) — shows the downside on EBITDA sensitivity.
Assumptions: Conway ramp delays or disappoints; coffee costs remain elevated, suppressing margins; liquidity crunch forces equity issuance at $4–5, diluting to 130M+ shares. FY2026E revenue misses ($1.1–1.2B); EBITDA stays near FY2025 levels (<$20M); lender negotiations consume management bandwidth.
Valuation: At 0.6–0.8x EV/Sales on $1.15B revenue (EV $690M–$920M), less elevated net debt of ~$560M (debt grows on continued cash burn) → equity value $130M–$360M. If dilution occurs (130M shares), per-share value $1.00–$2.77. Even at 0.5x P/S = $560M cap / 130M shares = $4.30. This is a genuine cash-burn/dilution scenario, not a mild haircut.
This report was generated using FMP financial data as of June 16, 2026. This is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results. Westrock Coffee Company (NASDAQ: WEST) is the coffee/beverage business — not West Pharmaceutical Services (WST) or WestRock packaging (now Smurfit WestRock).